Hims & Hers opened a pre-launch waitlist for Ozempic and Wegovy following a partnership with Novo Nordisk. Users signing up gain priority access when the drugs debut on the platform. Despite the news, HIMS shares dipped 1% in pre-market trading, while retail sentiment on Stocktwits remained bullish.